Kura Oncology (NASDAQ:KURA) Earns “Outperform” Rating from Wedbush
Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Wedbush in a research note issued to investors on Friday,Benzinga reports. They currently have a $36.00 target price on the stock. A number of other brokerages have also recently commented on KURA. JMP Securities reiterated a “market outperform” […]
Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reiterated by research analysts at Wedbush in a research note issued to investors on Friday,Benzinga reports. They currently have a $36.00 target price on the stock. A number of other brokerages have also recently commented on KURA. JMP Securities reiterated a “market outperform” […]
